A detailed history of Sfmg, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sfmg, LLC holds 7,091 shares of ABBV stock, worth $1.17 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,091
Previous 7,120 0.41%
Holding current value
$1.17 Million
Previous $1.3 Million 6.17%
% of portfolio
0.11%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $4,488 - $5,242
-29 Reduced 0.41%
7,091 $1.22 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $62,649 - $71,383
-392 Reduced 5.22%
7,120 $1.3 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $59,030 - $66,482
-429 Reduced 5.4%
7,512 $1.16 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $32,996 - $38,198
247 Added 3.21%
7,941 $1.18 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $8,348 - $10,388
-63 Reduced 0.81%
7,694 $1.04 Million
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $133,475 - $153,716
923 Added 13.51%
7,757 $1.24 Million
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $1.65 Million - $1.98 Million
-11,941 Reduced 63.6%
6,834 $0
Q3 2022

Oct 20, 2022

BUY
$134.21 - $153.93 $15,434 - $17,701
115 Added 0.62%
18,775 $2.63 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $799,296 - $1.02 Million
-5,808 Reduced 23.74%
18,660 $2.86 Million
Q1 2022

Apr 21, 2022

SELL
$131.98 - $163.75 $1.57 Million - $1.95 Million
-11,884 Reduced 32.69%
24,468 $3.97 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $163,723 - $207,157
1,524 Added 4.38%
36,352 $4.92 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $26,919 - $30,557
253 Added 0.73%
34,828 $3.76 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $12,204 - $13,596
-116 Reduced 0.33%
34,575 $3.9 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $213,193 - $234,700
2,084 Added 6.39%
34,691 $3.75 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $138,281 - $186,695
1,718 Added 5.56%
32,607 $3.49 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $415,374 - $487,513
4,835 Added 18.56%
30,889 $2.71 Million
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $31,695 - $42,413
432 Added 1.69%
26,054 $2.56 Million
Q1 2020

May 08, 2020

SELL
$64.5 - $97.79 $12,255 - $18,580
-190 Reduced 0.74%
25,622 $1.95 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $103,218 - $129,147
-1,431 Reduced 5.25%
25,812 $2.29 Million
Q3 2019

Oct 29, 2019

BUY
$62.98 - $75.72 $585,273 - $703,665
9,293 Added 51.77%
27,243 $2.06 Million
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $831,696 - $1.06 Million
12,659 Added 239.26%
17,950 $1.22 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $13,345 - $15,706
173 Added 3.38%
5,291 $426,000
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $3,269 - $4,032
-42 Reduced 0.81%
5,118 $472,000
Q3 2018

Nov 15, 2018

BUY
$88.91 - $98.84 $31,118 - $34,594
350 Added 7.28%
5,160 $411,000
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $8,978 - $10,623
100 Added 2.12%
4,810 $446,000
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $4,600 - $6,160
50 Added 1.07%
4,710 $446,000
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $88,216 - $96,736
985 Added 26.8%
4,660 $451,000
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $256,698 - $327,883
3,675
3,675 $327,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sfmg, LLC Portfolio

Follow Sfmg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.